title: [Treatment outcome of advanced Hodgkin's disease based on using an alternating program ChLVPP (chlorambucil, vinblastine, procarbazine, prednisone) and ABV (doxorubicin, bleomycin, vinblastine)].
abstract: Twenty nine patients (7 women, 22 men) with III and IV stage of Hodgkin's disease were treated according to alternating programme ChLVPP/ABV. The results were evaluated in 27 patients. Complete remission was obtained in 41% (11 patients), partial remission in 22% (6 patients). Applied treatment revealed a relatively small toxicity.
authors.affiliation: Klinika Hematologii Instytutu Chorób Wewnetrznych Akademii Medycznej im. K. Marcinkowskiego, Poznaniu.
authors.forename: M
authors.initials: M
authors.lastname: Komarnicki
authors.forename: A
authors.initials: A
authors.lastname: Balcerzak
authors.forename: P
authors.initials: P
authors.lastname: Górski
authors.forename: L
authors.initials: L
authors.lastname: Pawlak
authors.forename: J
authors.initials: J
authors.lastname: Hansz
mesh_terms: D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001761:Bleomycin / Q000008:administration & dosage; D002699:Chlorambucil / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D005260:Female; D006689:Hodgkin Disease / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D011239:Prednisolone / Q000008:administration & dosage; D011344:Procarbazine / Q000008:administration & dosage; D012074:Remission Induction; D014747:Vinblastine / Q000008:administration & dosage
chemical_list: D001761:Bleomycin; D002699:Chlorambucil; D011344:Procarbazine; D014747:Vinblastine; D004317:Doxorubicin; D011239:Prednisolone